National and Kapodistrian University of Athens
Έλεγχος επίδρασης της μετφορμίνης στον άξονα υποθαλάμου - υπόφυσης και της σχέσης έκκρισης ινσουλίνης, επιπέδων γλυκόζης και γοναδικών ορμονών στις γυναίκες με σύνδρομο πολυκυστικών ωοθηκών
Abstract
dc:descriptionImprovement of insulin resistance following metformin (MET) administration has been associated with more frequent ovulatory events and relative shortening of spontaneous cycles’ duration in women with polycystic ovary syndrome (PCOS). This effect has been attributed, among other factors, to a modification of hypothalamic-pituitary activity in PCOS, which, however has not been adequately investigated so far. The aims of the present study was the evaluation of pituitary function and metabolic axis before and after MET administration in women with PCOS in comparison with appropriate controls. A total of 64 women, aged 19-33 years, were included in the study and were randomly allocated into the following groups: 1. PCOS women (n=32) and 2. Women with a normal menstrual cycle (n=32). MET (1700 mg/d) or placebo was given to each half of the individual groups of women. The protocol of the study included: an initial evaluation cycle and a subsequent intervention cycle. The evaluation included anthropometric parameters, ovarian morphology by ultrasound, biochemical/haematological studies and monitoring of ovulation and luteal function. Endocrine evaluation included basal measurements of sex steroids and thyroid hormones and GnRH and TRH tests. Metabolic assessment included per os glucose tolerance test (75 g) with insulin measurements performed on days on 3rd - 4th day of the cycle. Evaluation was repeated after a cycle of intervention treatment with MET or placebo. The results found was as follows: 1. Ovulation during MET administration in PCOS women was established in 60.0% of the cases whereas in placebo treated women only in 26.6%. In normal controls, ovulation was observed in 100.0% in both groups of treatment. 2. Basal insulin concentration was lowered (p<0.05) and the Quicky index increased (p<0.05) in PCOS women after MET administration. 3. PCOS women showed a decrease in AURC for LH (p<0.05) after MET administration compared to placebo group. 5. PCOS responding to MET with ovulation had greater Quicky index (p<0.05), lower basal LH levels, AURC for LH and AURC for PRL (p<0.05 for all) after MET than non -responders. In conclusion, in MET-treated PCOS there was a decline in insulin secretion and insulin resistance while in those who responded with ovulation, there was a marked rise in Quicky index and a decline in LH levels, AURCLH and AURCprl as compared to anovulatory cases. These findings are indicative of an effect of MET, direct or indirect, on pituitary and, tentatively, hypothalamic (?) function in women with PCOS.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Billa, Evangelia
- Μπίλλα, Ευαγγελία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23796